We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$2.09B
AUM Growth
+$127M
(+6.5%)
Cap. Flow
+$96.6M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
59.89%
Holding
266
New
179
Increased
23
Reduced
16
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEST
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
|
+$56.6M |
| 2 |
VRAY
ViewRay, Inc.
VRAY
|
+$26.6M |
| 3 |
SINA
Sina Corp
SINA
|
+$13.2M |
| 4 |
Bilibili
BILI
|
+$12M |
| 5 |
Deutsche Bank
DB
|
+$9.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIFU
AIFU Inc
AIFU
|
+$83.3M |
| 2 |
MOMO
Hello Group
MOMO
|
+$48.4M |
| 3 |
VER
VEREIT, Inc.
VER
|
+$39.1M |
| 4 |
BZUN
Baozun
BZUN
|
+$20.7M |
| 5 |
CF Industries
CF
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.37% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 4.86% |
| 4 | Communication Services | 3.13% |
| 5 | Industrials | 2.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AtriCure
ATRC
$1.89B
| $6.86M | 0.33% |
+197,459
| New | +$6.25M |
|
|
SGEN
27
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.82M | 0.33% |
+87,105
| New | +$6.42M |
|
28
Ironwood Pharmaceuticals
IRWD
$644M
| $6.36M | 0.31% |
+415,155
| New | +$6.56M |
|
|
ARRY
29
DELISTED
Array Biopharma Inc
ARRY
| $6.35M | 0.3% |
+430,055
| New | +$6.59M |
|
30
BeyondSpring
BYSI
$48.1M
| $6M | 0.29% |
240,000
| – | – |
|
31
Viatris
VTRS
$20.5B
| $5.97M | 0.29% |
163,000
| – | – |
|
|
SDRL
32
DELISTED
Seadrill Limited Common Stock
SDRL
| $5.76M | 0.28% |
+232,606
| New | +$4.72M |
|
33
Mastercard
MA
$487B
| $5.74M | 0.28% |
25,840
-5,610
| -18% | -$1.17M |
|
34
Merck
MRK
$323B
| $5.67M | 0.27% |
+83,945
| New | +$5.35M |
|
35
Microsoft
MSFT
$2.89T
| $5.63M | 0.27% |
49,208
+26,818
| +120% | +$2.91M |
|
|
DOVA
36
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $5.49M | 0.26% |
261,780
-27,903
| -10% | -$665K |
|
37
Visa
V
$689B
| $5.44M | 0.26% |
36,290
+23,800
| +191% | +$3.38M |
|
38
Neurocrine Biosciences
NBIX
$17.7B
| $5.19M | 0.25% |
+43,100
| New | +$4.89M |
|
39
Brookfield Renewable
BEP
$9.74B
| $5.15M | 0.25% |
+187,650
| New | +$3.08M |
|
|
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
| $5.15M | 0.25% |
+463,807
| New | +$5.76M |
|
41
Brookfield
BN
$103B
| $5.12M | 0.25% |
+322,314
| New | +$4.9M |
|
|
FOLD
42
DELISTED
Amicus Therapeutics
FOLD
| $5.08M | 0.24% |
+414,796
| New | +$5.8M |
|
43
Cognizant
CTSH
$22.3B
| $5.07M | 0.24% |
66,050
+60,730
| +1,142% | +$4.75M |
|
|
DCPH
44
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.96M | 0.24% |
+128,037
| New | +$4.73M |
|
|
TSRO
45
DELISTED
TESARO, Inc.
TSRO
| $4.94M | 0.24% |
+128,600
| New | +$4.54M |
|
46
Meta Platforms (Facebook)
META
$1.51T
| $4.75M | 0.23% |
28,130
+19,170
| +214% | +$3.47M |
|
47
Acadia Pharmaceuticals
ACAD
$4.35B
| $4.56M | 0.22% |
+209,000
| New | +$3.29M |
|
48
Cardinal Health
CAH
$53.7B
| $4.44M | 0.21% |
82,265
+19,810
| +32% | +$1.01M |
|
49
Amazon
AMZN
$2.49T
| $4.44M | 0.21% |
+44,100
| New | +$4.15M |
|
50
ConocoPhillips
COP
$141B
| $3.95M | 0.19% |
+50,900
| New | +$3.67M |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
MHC
BWM
Fosun International's Q3 2018 Portfolio in Review
As of Q3 2018, Fosun International held 266 positions worth $2.09B, up 6.5% from $1.96B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Fosun International deployed $96.6M of net new capital in Q3 2018, opening 179 new positions and adding to 23 existing holdings. Its largest new stake was BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares: 331,701 shares worth $39.3M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amneal Pharmaceuticals, an estimated $15.6M trimmed.
- Fosun International's largest Q3 2018 buy was BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares: 331,701 shares worth $39.3M.
- Fosun International added most to ViewRay, Inc. in Q3 2018, an estimated $26.6M increase.
- Fosun International's biggest Q3 2018 reduction was Amneal Pharmaceuticals, cutting an estimated $15.6M.
- Fosun International fully exited AIFU Inc in Q3 2018, selling an estimated $83.3M.
- Fosun International's ten largest holdings make up 60% of its $2.09B portfolio in Q3 2018.
- Fosun International opened 179 new positions and closed 20 in Q3 2018.
- Fosun International's portfolio value rose 6.5% quarter-over-quarter to $2.09B.
Based on Fosun International's 13F filing for Q3 2018, filed 9 Nov 2018.